Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4njo | NAD | D-3-phosphoglycerate dehydrogenase, putative |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4njo | NAD | D-3-phosphoglycerate dehydrogenase, putative | / | 1.000 | |
| 2w2l | NAD | D-mandelate dehydrogenase | / | 0.524 | |
| 3kb6 | NAD | D-lactate dehydrogenase | / | 0.511 | |
| 2g76 | NAD | D-3-phosphoglycerate dehydrogenase | 1.1.1.95 | 0.495 | |
| 2dbz | NAP | Glyoxylate reductase | 1.1.1.26 | 0.492 | |
| 2ome | NAD | C-terminal-binding protein 2 | / | 0.476 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.475 | |
| 4lcj | NAD | C-terminal-binding protein 2 | / | 0.474 | |
| 2gcg | NDP | Glyoxylate reductase/hydroxypyruvate reductase | 1.1.1.79 | 0.469 | |
| 5jsf | NAD | 17-beta-hydroxysteroid dehydrogenase 14 | 1.1.1 | 0.463 | |
| 4nu6 | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.462 | |
| 4e5k | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.461 | |
| 4nu5 | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.461 | |
| 3baz | NAP | Hydroxyphenylpyruvate reductase | 1.1.1.237 | 0.460 | |
| 4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.460 | |
| 2dbq | NAP | Glyoxylate reductase | 1.1.1.26 | 0.459 | |
| 4nbt | NAD | 3-oxoacyl-[acyl-carrier-protein] reductase | / | 0.458 | |
| 3f03 | FMN | Pentaerythritol tetranitrate reductase | / | 0.457 | |
| 5js6 | NAD | 17-beta-hydroxysteroid dehydrogenase 14 | 1.1.1 | 0.457 | |
| 2dbr | NAP | Glyoxylate reductase | 1.1.1.26 | 0.456 | |
| 4dpu | AGS | Mevalonate diphosphate decarboxylase | / | 0.456 | |
| 3nd1 | SAH | Precorrin-6A synthase (Deacetylating) | / | 0.454 | |
| 1dxy | NAD | D-2-hydroxyisocaproate dehydrogenase | 1.1.1 | 0.452 | |
| 1hdg | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.452 | |
| 4hwk | NAP | Sepiapterin reductase | 1.1.1.153 | 0.452 | |
| 1hku | NAD | C-terminal-binding protein 1 | 1.1.1 | 0.451 | |
| 4e5m | NAP | Phosphonate dehydrogenase | 1.20.1.1 | 0.450 | |
| 4weq | NAP | NAD-dependent dehydrogenase | / | 0.450 | |
| 1h50 | FMN | Pentaerythritol tetranitrate reductase | / | 0.447 | |
| 2abb | FMN | Pentaerythritol tetranitrate reductase | / | 0.447 | |
| 2o1s | TDP | 1-deoxy-D-xylulose-5-phosphate synthase | 2.2.1.7 | 0.446 | |
| 3drc | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
| 3tri | NAP | Pyrroline-5-carboxylate reductase | / | 0.446 | |
| 4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
| 1b5d | DCM | Deoxycytidylate 5-hydroxymethyltransferase | 2.1.2.8 | 0.445 | |
| 1h63 | FMN | Pentaerythritol tetranitrate reductase | / | 0.445 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
| 1ci7 | UMP | Thymidylate synthase | 2.1.1.45 | 0.444 | |
| 2d1y | NAD | Oxidoreductase, short-chain dehydrogenase/reductase family | / | 0.444 | |
| 3wv7 | ADP | Hmd co-occurring protein HcgE | / | 0.444 | |
| 4z0p | NDP | NAD-dependent dehydrogenase | / | 0.444 | |
| 5jla | NAD | Putative short-chain dehydrogenase/reductase | / | 0.444 | |
| 2gv8 | FAD | Thiol-specific monooxygenase | 1.14.13 | 0.442 | |
| 4zju | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.442 | |
| 3p62 | FMN | Pentaerythritol tetranitrate reductase | / | 0.441 | |
| 1cul | FOK | Adenylate cyclase type 2 | / | 0.440 | |
| 1cul | FOK | Adenylate cyclase type 5 | / | 0.440 | |
| 2g0n | GDP | Ras-related C3 botulinum toxin substrate 3 | / | 0.440 | |
| 4hbm | 0Y7 | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.440 |